PHVS Stock Analysis: Buy, Sell, or Hold?
PHVS - Pharvaris N.V. Ordinary Shares
$36.27
-0.12 (-0.33%)
▼
5d:
+3.22%
30d:
+9.05%
90d:
+18.76%
WAIT
LOW Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Aug 11, 2026
0d
Smart Money Distribution
Options positioning is turning defensive after a sharp run-up - a pattern consistent with institutional profit-taking. View Scanner →
Signal fired Aug 13, 2026 at $34.04 · last confirmed Aug 17, 2026
Strength: 6.5/10
Get Alerted When PHVS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: PHVS shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: PHVS shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: PHVS is currently trading at $36.27, which is considered extended relative to its 30-day fair value range of $33.30 to $35.59.
Technical Outlook: Technically, PHVS is in a strong uptrend. The price is approaching resistance at $36.93. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: PHVS scores 29/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $48.83 (+34.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, PHVS is in a strong uptrend. The price is approaching resistance at $36.93. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: PHVS scores 29/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $48.83 (+34.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$33.30 -
$35.59
Company Quality Score
44/100
(HOLD)
Options IV Signal
38th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
35.4%
Protect Your Profits
Holding PHVS? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range
- NEUTRAL: Options fairly priced (IV 38th percentile)
- BEARISH: Weak technical setup (29/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 34.2% below Wall St target ($48.83)
- WARNING: Composite score 44/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$33.30 -
$35.59
Current vs Trading Range
EXTENDED
Expected Move (7 Days)
±$4.99
(13.8%)
Support & Resistance Levels
Support Level
$33.00
Resistance Level
$36.93
Current Trend
Strong Uptrend
Technical data as of
Aug 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-13.58
Wall Street Target
$48.83
(+34.2%)
Share & Embed Analysis
Last updated: August 23, 2026 3:40 AM ET
Data refreshes hourly during market hours. Next update: 4:40 AM
Data refreshes hourly during market hours. Next update: 4:40 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PHVS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
9
Sells
Net
INSIDERS SELLING
Recent Transactions
Anne Lesage
SELL
100 shares
2026-04-23
Johannes Gerardus Chri S…
SELL
100 shares
2026-04-23
Peng Lu
SELL
100 shares
2026-04-23
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$81 | 58 HOLD |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$53 | 57 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$92 | 54 HOLD |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$9 | 53 HOLD |
|
BEAM
Beam Therapeutics Inc |
STRONG BUY
17 analysts |
$52 | 42 HOLD |
Advanced PHVS Option Strategies
Professional options setups generated by AI based on today's PHVS price and gamma walls.
